Cloprostenol

Brand names: Synchsure · Active ingredient: Cloprostenol Sodium

LabelBoehringer Ingelheim Animal Health USA Inc.
Label updatedJan 06, 2025

Cloprostenol dosage

Two mL of SYNCHSURE (500 mcg cloprostenol) should be administered by INTRAMUSCULAR INJECTION using the specific dosage regimen for the indication.

Discard remaining product 180 days after first use.

1. For unobserved or non-detected estrus in beef cows, lactating dairy cows, and replacement beef and dairy heifers

Cows and heifers which are not detected in estrus, although ovarian cyclicity continues, can be treated with SYNCHSURE if a mature corpus luteum is present. Estrus is expected to occur 2 to 5 days following injection, at which time animals may be inseminated. Treated cattle should be inseminated at the usual time following detection of estrus. If estrous detection is not desirable or possible, treated animals may be inseminated twice at about 72 and 96 hours post-injection.

2. For treatment of pyometra or chronic endometritis in beef cows, lactating dairy cows, and replacement beef and dairy heifers

Damage to the reproductive tract at calving or postpartum retention of the placenta often leads to infection and inflammation of the uterus (endometritis). Under certain circumstances, this may progress into chronic endometritis with the uterus becoming distended with purulent matter. This condition, commonly referred to as pyometra, is characterized by a lack of cyclical estrous behavior and the presence of a persistent corpus luteum. Induction of luteolysis with SYNCHSURE usually results in evacuation of the uterus and a return to normal cyclical activity within 14 days after treatment. After 14 days post-treatment, recovery rate of treated animals will not be different than that of untreated cattle.

3. For treatment of mummified fetus in beef cows, lactating dairy cows, and replacement beef and dairy heifers

Death of the conceptus during gestation may be followed by its degeneration and dehydration. Induction of luteolysis with SYNCHSURE usually results in expulsion of the mummified fetus from the uterus. (Manual assistance may be necessary to remove the fetus from the vagina). Normal cyclical activity usually follows.

4. For treatment of luteal cysts in beef cows, lactating dairy cows, and replacement beef and dairy heifers

A cow or heifer may be noncyclic due to the presence of a luteal cyst (a single, anovulatory follicle with a thickened wall which is accompanied by no external signs and by no changes in palpable consistency of the uterus). Treatment with SYNCHSURE can restore normal ovarian activity by causing regression of the luteal cyst.

5. For abortion of beef cows, lactating dairy cows, and replacement beef and dairy heifers

Unwanted pregnancies can be safely and efficiently terminated from 1 week after mating until about 5 months of gestation. …

Warnings & precautions

Do not take this medicine if: Do not use this drug product in pregnant cattle, unless abortion is desired.

WITHDRAWAL PERIODS AND RESIDUE WARNINGS:

No milk discard or pre-slaughter drug withdrawal period is required when used according to labeling. Use of this product in excess of the approved dose may result in drug residues.

USER SAFETY WARNINGS:

Not for use in humans. Keep this and all drugs out of the reach of children.

Women of childbearing age, asthmatics, and persons with bronchial and other respiratory problems should exercise extreme caution when handling this product.

SYNCHSURE is readily absorbed through the skin and can cause abortion and/or bronchospasms. Direct contact with the skin should therefore be avoided. Accidental spillage on the skin should be washed off immediately with soap and water.

The Safety Data Sheet (SDS) contains more detailed occupational safety information. To obtain an SDS or for technical assistance, contact Boehringer Ingelheim Animal Health USA Inc. at 1-888-637-4251.

ANIMAL SAFETY WARNINGS:

As with all parenteral products, careful aseptic techniques should be employed to decrease the possibility of post-injection bacterial infection. Severe localized clostridial infections associated with injection of cloprostenol injection have been reported. In rare instances, such infections have resulted in death. Aggressive antibiotic therapy should be employed at the first sign of infection at the injection site, whether localized or diffuse.

At 50 and 100 times the recommended dose, mild side effects may be detected in some cattle. These include increased uneasiness, slight frothing, and milk let-down.

About this medicine

SYNCHSURE (cloprostenol injection) is a synthetic prostaglandin analogue structurally related to prostaglandin F2α (PGF2α). Each mL of the sterile colorless aqueous solution contains 250 mcg cloprostenol (equivalent to 263 mcg cloprostenol sodium), 5.03 mg sodium citrate, 0.66 mg anhydrous citric acid, 6.76 mg sodium chloride, 1.0 mg chlorocresol, and water for injection q.s.

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID bbec63d2-59ce-44d8-9190-e4ce483ee880. Read the full official label on DailyMed.